Theon Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 02-11-2024
- Paid Up Capital ₹ 5.50 Cr
as on 02-11-2024
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.00 Cr
as on 02-11-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 3462.31%
(FY 2023)
About Theon Lifesciences
The Corporate was formerly known as Theon Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.50 Cr.
The company currently has active open charges totaling ₹30.00 Cr.
Puneet Bansal, Manish Bansal, and Puran Joshi serve as directors at the Company.
- CIN/LLPIN
U24290HR2021PTC097033
- Company No.
097033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Theon Lifesciences?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Puneet Bansal | Director | 16-Aug-2021 | Current |
Manish Bansal | Director | 16-Aug-2021 | Current |
Puran Joshi | Whole-Time Director | 11-Sep-2021 | Current |
Financial Performance of Theon Lifesciences.
Theon Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Theon Lifesciences?
In 2023, Theon Lifesciences had a promoter holding of 99.90% and a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Iva Healthcare Private LimitedActive 15 years 11 months
Puneet Bansal, Manish Bansal and 1 more are mutual person
- Theon Pharmaceuticals LimitedActive 19 years 6 months
Puneet Bansal, Manish Bansal and 1 more are mutual person
- Theon Wellness Private LimitedActive 6 years 3 months
Puneet Bansal and Manish Bansal are mutual person
- Jenisha Enterprises Private LimitedActive 3 years 1 month
Puneet Bansal and Manish Bansal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 06 May 2024 | ₹3.00 Cr | Open |
Others Creation Date: 10 Apr 2024 | ₹27.00 Cr | Open |
How Many Employees Work at Theon Lifesciences?
Theon Lifesciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theon Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theon Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.